COMMUNIQUÉS West-GlobeNewswire
-
AB Science announces issuance of a European patent for masitinib in the treatment of severe mastocytosis with protection until 2036
13/05/2024 -
AB Science annonce la délivrance d’un brevet européen pour le masitinib dans le traitement de la mastocytose sévère avec une protection jusqu’en 2036
13/05/2024 -
Safe signs a strategic partnership in the United States with a californian hospital group
13/05/2024 -
Safe signe un partenariat stratégique aux Etats-Unis avec un groupe d’hôpitaux californien
13/05/2024 -
Informations relatives au nombre total de droits de vote et d’actions composant le capital
13/05/2024 -
Evelyne Nguyen appointed EUROAPI’s Chief Financial Officer
13/05/2024 -
Evelyne Nguyen est nommée Directrice financière d’EUROAPI
13/05/2024 -
Novo Nordisk A/S: Once-weekly and once-monthly Mim8 demonstrate superior reduction of treated bleeding episodes compared to on-demand and prior prophylaxis treatment in people with haemophilia A in the Frontier 2 trial
13/05/2024 -
Pennant Group to Participate in the 2024 RBC Global Healthcare Conference
13/05/2024 -
Trinity Biotech Announces Increased Orders for TrinScreen HIV and Raises Guidance for 2024 TrinScreen HIV Sales
13/05/2024 -
Blue Cross and Blue Shield of Minnesota Collaborate with Black Market Reads Podcast to Highlight Racial and Health Inequities Impacting Black Communities
13/05/2024 -
Transactions in Connection with Share Buy-back Program
13/05/2024 -
King Faisal Specialist Hospital and Research Centre Welcomes New Deputy CEO Amid Strategic Transformations
13/05/2024 -
Cytokinetics Announces Primary Results From SEQUOIA-HCM Presented in Late Breaking Clinical Trial Session at the European Society of Cardiology Heart Failure 2024 Congress and Published in the New England Journal of Medicine
13/05/2024 -
Cytokinetics Announces Additional Results From SEQUOIA-HCM Presented in Late Breaking Clinical Trial Session at the European Society of Cardiology Heart Failure 2024 Congress
13/05/2024 -
Scilex Holding Company Provides Information to Scilex Stockholders Regarding Manipulative and Naked Short Selling of Scilex Common Stock
13/05/2024 -
Baylor Genetics Launches RNASeq Test for Whole Genome and Whole Exome Sequencing, Reduces Turnaround Times, Introduces Four New Genetic Analysis Panels
13/05/2024 -
Outlook Therapeutics® Announces UK Submission of Marketing Authorization Application (MAA) for ONS-5010 as a Treatment for Wet AMD
13/05/2024 -
Safety Shot Partners with Gopuff
13/05/2024
Pages